Table of Content

1. Executive Summary
   1.1. North America Contraceptive Drugs Market Snapshot, 2024 and 2031
   1.2. Market Opportunity Assessment, 2024 - 2031, US$ Mn
   1.3. Key Market Trends
   1.4. Future Market Projections
   1.5. Premium Market Insights
   1.6. Industry Developments and Key Market Events
   1.7. PMR Analysis and Recommendations
2. Market Overview
   2.1. Market Scope and Definition
   2.2. Market Dynamics
       2.2.1. Drivers
       2.2.2. Restraints
       2.2.3. Opportunity
       2.2.4. Key Trends
   2.3. Macro-Economic Factors
       2.3.1. Global GDP Growth Outlook
       2.3.2. Global Healthcare Spending Outlook
   2.4. COVID-19 Impact Analysis
   2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   3.1. Drug Adoption Analysis
   3.2. Regulatory Landscape
   3.3. Value Chain Analysis
   3.4. Key Deals and Mergers
   3.5. PESTLE Analysis
   3.6. Porter’s Five Force Analysis
4. North America Contraceptive Drugs Market Outlook: Historical (2018 - 2022) and Forecast (2024 - 2031)
   4.1. North America Contraceptive Drugs Market Outlook: Type
       4.1.1. Introduction / Key Findings
       4.1.2. Historical Market Size (US$ Mn) Analysis, By Type, 2018 - 2022
       4.1.3. Current Market Size (US$ Mn) Analysis and Forecast, By Type, 2023 - 2031
           4.1.3.1. Oral Contraceptives
           4.1.3.2. Injectables
           4.1.3.3. Implants
           4.1.3.4. Others
       4.1.4. Market Attractiveness Analysis: Type
   4.2. North America Contraceptive Drugs Market Outlook: Distribution Channel
       4.2.1. Introduction / Key Findings
       4.2.2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2018 - 2022
       4.2.3. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
           4.2.3.1. Retail Pharmacies
           4.2.3.2. Online Pharmacies
           4.2.3.3. Hospitals and Clinics
           4.2.3.4. Others
       4.2.4. Market Attractiveness Analysis: Distribution Channel
5. North America Contraceptive Drugs Market Outlook: Country
   5.1. Key Highlights
   5.2. Historical Market Size (US$ Mn) Analysis, By Country, 2018 - 2022
   5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       5.3.1. U.S.
       5.3.2. Canada
   5.4. Market Attractiveness Analysis: Country
6. Competition Landscape
   6.1. Market Share Analysis, 2023
   6.2. Market Structure
       6.2.1. Competition Intensity Mapping By Market
       6.2.2. Competition Dashboard
   6.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       6.3.1. Church & Dwight Co., Inc.
           6.3.1.1. Overview
           6.3.1.2. Segments and Products
           6.3.1.3. Key Financials
           6.3.1.4. Market Developments
           6.3.1.5. Market Strategy
       6.3.2. Reckitt Benckiser Group Plc
       6.3.3. Veru, Inc.
       6.3.4. Organon Group of Companies
       6.3.5. Pfizer, Inc.
       6.3.6. Teva Pharmaceutical Industries Ltd.
       6.3.7. The Cooper Companies, Inc.
       6.3.8. Mayer Laboratories, Inc.
       6.3.9. Agile Therapeutics
       6.3.10. TherapeuticsmMD, Inc.
       6.3.11. Bayer Ag
       6.3.12. Afaxys, Inc.
       6.3.13. Mithra Pharmaceuticals
       6.3.14. Abbvie
       6.3.15. Others
7. Appendix
   7.1. Research Methodology
   7.2. Research Assumptions
   7.3. Acronyms and Abbreviations